Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
Abstract: The therapeutic efficacy of imidocarb, artesunate, arteether, buparvaquone and arteether+buparvaquone combination was evaluated against Babesia equi of Indian origin in splenectomised donkeys with experimentally induced acute infection. Efficacies of these drugs were tested by administering each drug or drug combination to groups of donkeys (having three donkeys each group). One group of donkey was kept as untreated control for comparing the results. Parasitaemia, haematology (WBC, RBC, PCV, granulocytes and haemoglobin), biochemical parameters (SAST, SALT, alkaline phosphatase, albumin/globulin ratio) were monitored at regular intervals. Individually, arteether and buparvaquone were found to have no parasite clearing efficacy and the treated animals died within 5-6 days after showing high parasitaemia and clinical symptoms of the disease. However, artesunate treated animals were able to restrict the parasite multiplication but only during the treatment period. Animals treated with imidocarb and arteether+buparvaquone combination were able to clear the parasite from the blood circulation after 2-5 days post-treatment (PT). After 55-58 days PT, recrudescence of B. equi parasite was observed in both these groups and a mean survival period of 66 days and 69 days, respectively, was recorded in these groups. Results of haemato-biochemical parameters had shown that imidocarb had deleterious effect on the liver function while on the other hand arteether+buparvaquone combination was found to be safe. This limited study indicates that arteether+buparvaquone combination could be a better choice than imidocarb for treating B. equi infection, but further trials are required in detail.
Publication Date: 2003-12-11 PubMed ID: 14665744DOI: 10.1292/jvms.65.1171Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Clinical Trial
- Comparative Study
- Journal Article
- Randomized Controlled Trial
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research examines the potential effectiveness of various drugs and drug combinations in treating Babesia equi (a parasite) infection in donkeys. The results suggest that a combination of arteether and buparvaquone might be a safer and more effective cure than imidocarb, but asserts that more detailed trials are necessary.
Research Methodology
- The study aimed to evaluate the therapeutic efficiency of certain drugs. These drugs are namely imidocarb, artesunate, arteether, buparvaquone and a combination of arteether and buparvaquone against Babesia equi, a parasite of Indian origin.
- Donkeys that were experimentally induced with an acute infection were used. They were splenectomised, meaning they had their spleens removed, as a part of the experiment.
- The drugs were administered to different groups, each consisting three donkeys. One of these groups was kept as an untreated control to compare the results effectively.
Parameters Monitored and Findings
- The research extensively monitored several parameters including parasitaemia, haematological factors (WBC, RBC, PCV, granulocytes and haemoglobin), and biochemical parameters (SAST, SALT, alkaline phosphatase, and albumin/globulin ratio).
- Singly, neither arteether nor buparvaquone could clear the parasite. Donkeys administered with these singular drugs died within 5-6 days due to high parasitaemia and noticeable symptoms of the disease.
- Whereas, with artesunate, the parasite multiplication was restricted but only during the treatment period.
- Only the imidocarb and the combination of arteether and buparvaquone were effective in completely removing the parasite from the blood circulation, and that too after 2-5 days of treatment.
Recurrences, Survival and Side Influence
- Recurrence of B. equi parasite was noted in both the imidocarb and the combination group post 55-58 days of treatment. The survival period for these groups was an average of 66 and 69 days respectively.
- Imidocarb manifested a negative impact on liver function while the combination of arteether and buparvaquone did not, indicating the latter to be safer.
- The preliminary study therefore concludes that the combination could be a better choice against B. equi infection than using imidocarb. However, it also emphasises the need for further in-depth trials to confirm this finding.
Cite This Article
APA
Kumar S, Gupta AK, Pal Y, Dwivedi SK.
(2003).
In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
J Vet Med Sci, 65(11), 1171-1177.
https://doi.org/10.1292/jvms.65.1171 Publication
Researcher Affiliations
- National Research Centre on Equines, Haryana, India.
MeSH Terms
- Animals
- Antiprotozoal Agents / administration & dosage
- Antiprotozoal Agents / therapeutic use
- Artemisinins / administration & dosage
- Artemisinins / therapeutic use
- Babesiosis / drug therapy
- Babesiosis / veterinary
- Blood Cell Count / veterinary
- Drug Therapy, Combination
- Equidae / blood
- Equidae / parasitology
- Imidocarb / administration & dosage
- Imidocarb / analogs & derivatives
- Imidocarb / therapeutic use
- India
- Naphthoquinones / administration & dosage
- Naphthoquinones / therapeutic use
- Sesquiterpenes / administration & dosage
- Sesquiterpenes / therapeutic use
- Splenectomy / veterinary
Citations
This article has been cited 19 times.- Barman M, Dandasena D, Suresh A, Bhandari V, Kamble S, Singh S, Subudhi M, Sharma P. Artemisinin derivatives induce oxidative stress leading to DNA damage and caspase-mediated apoptosis in Theileria annulata-transformed cells. Cell Commun Signal 2023 Apr 17;21(1):78.
- Graham H, van Kalsbeek P, van der Goot J, Koene MGJ. Low seroprevalence of equine piroplasmosis in horses exported from the Netherlands between 2015 and 2021. Front Vet Sci 2022;9:954046.
- Zhang Y, Alvarez-Manzo H, Leone J, Schweig S, Zhang Y. Botanical Medicines Cryptolepis sanguinolenta, Artemisia annua, Scutellaria baicalensis, Polygonum cuspidatum, and Alchornea cordifolia Demonstrate Inhibitory Activity Against Babesia duncani. Front Cell Infect Microbiol 2021;11:624745.
- Hines SA, Brandvold J, Mealey RH, Call DR, Graça T. Exposure to ambient air causes degradation and decreased in vitro potency of buparvaquone and parvaquone. Vet Parasitol X 2020 May;3:100023.
- Carvalho LJM, Tuvshintulga B, Nugraha AB, Sivakumar T, Yokoyama N. Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo. Parasit Vectors 2020 Jul 20;13(1):362.
- Gugliandolo E, Palma E, Peritore AF, Siracusa R, D'Amico R, Fusco R, Licata P, Crupi R. Effect of Artesunate on Leishmania Amazonesis Induced Neuroinflammation and Nociceptive Behavior in Male Balb/C Mice. Animals (Basel) 2020 Mar 27;10(4).
- Checa R, Montoya A, Ortega N, González-Fraga JL, Bartolomé A, Gálvez R, Marino V, Miró G. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Parasit Vectors 2017 Mar 13;10(1):145.
- Van Voorhis WC, Doggett JS, Parsons M, Hulverson MA, Choi R, Arnold SLM, Riggs MW, Hemphill A, Howe DK, Mealey RH, Lau AOT, Merritt EA, Maly DJ, Fan E, Ojo KK. Extended-spectrum antiprotozoal bumped kinase inhibitors: A review. Exp Parasitol 2017 Sep;180:71-83.
- Loo CS, Lam NS, Yu D, Su XZ, Lu F. Artemisinin and its derivatives in treating protozoan infections beyond malaria. Pharmacol Res 2017 Mar;117:192-217.
- Laus F, Spaterna A, Faillace V, Veronesi F, Ravagnan S, Beribé F, Cerquetella M, Meligrana M, Tesei B. Clinical investigation on Theileria equi and Babesia caballi infections in Italian donkeys. BMC Vet Res 2015 Apr 28;11:100.
- Wunderlich F, Al-Quraishy S, Steinbrenner H, Sies H, Dkhil MA. Towards identifying novel anti-Eimeria agents: trace elements, vitamins, and plant-based natural products. Parasitol Res 2014 Oct;113(10):3547-56.
- Drăgan L, Györke A, Ferreira JF, Pop IA, Dunca I, Drăgan M, Mircean V, Dan I, Cozma V. Effects of Artemisia annua and Foeniculum vulgare on chickens highly infected with Eimeria tenella (phylum Apicomplexa). Acta Vet Scand 2014 Apr 15;56(1):22.
- Ueti MW, Mealey RH, Kappmeyer LS, White SN, Kumpula-McWhirter N, Pelzel AM, Grause JF, Bunn TO, Schwartz A, Traub-Dargatz JL, Hendrickson A, Espy B, Guthrie AJ, Fowler WK, Knowles DP. Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk. PLoS One 2012;7(9):e44713.
- O'Neill PM, Barton VE, Ward SA. The molecular mechanism of action of artemisinin--the debate continues. Molecules 2010 Mar 12;15(3):1705-21.
- Cui L, Su XZ. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther 2009 Oct;7(8):999-1013.
- Rajput R, Prajapati A, Srivastava A. Targeting piroplasmosis and theileriosis: New frontiers in drug development. Trop Anim Health Prod 2025 Dec 9;57(9):529.
- Cardillo NM, Villarino NF, Lacy PA, Doggett JS, Riscoe MK, Suarez CE, Ueti MW, Chung CJ. Enhanced Anti-Babesia Efficacy of Buparvaquone and Imidocarb When Combined with ELQ-316 In Vitro Culture of Babesia bigemina. Pharmaceuticals (Basel) 2025 Feb 6;18(2).
- Mendoza FJ, Pérez-Écija A, Kappmeyer LS, Suarez CE, Bastos RG. New insights in the diagnosis and treatment of equine piroplasmosis: pitfalls, idiosyncrasies, and myths. Front Vet Sci 2024;11:1459989.
- Cardillo NM, Lacy PA, Villarino NF, Doggett JS, Riscoe MK, Bastos RG, Laughery JM, Ueti MW, Suarez CE. Comparative efficacy of buparvaquone and imidocarb in inhibiting the in vitro growth of Babesia bovis. Front Pharmacol 2024;15:1407548.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
